Suleyha Hilmioglu-Polat
Overview
Explore the profile of Suleyha Hilmioglu-Polat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Unal N, Spruijtenburg B, Arastehfar A, Gumral R, de Groot T, Meijer E, et al.
Mycoses
. 2024 Nov;
67(11):e70000.
PMID: 39547949
Objectives: Worldwide emergence of clonal outbreaks caused by fluconazole-resistant (FLCR) and the recent emergence of echinocandin- and multidrug-resistant (ECR and MDR) Candida parapsilosis isolates pose serious threats to modern clinics....
2.
Daneshnia F, Floyd D, Ryan A, Ghahfarokhy P, Ebadati A, Jusuf S, et al.
Emerg Microbes Infect
. 2024 Feb;
13(1):2322655.
PMID: 38380673
is known to cause severe and persistent outbreaks in clinical settings. Patients infected with multidrug-resistant (MDR Cp) isolates were identified in a large Turkish hospital from 2017-2020. We subsequently identified...
3.
Karakoyun A, Spruijtenburg B, Unal N, Meijer E, Sucu M, Hilmioglu-Polat S, et al.
Med Mycol
. 2024 Jan;
62(2).
PMID: 38289726
Candida krusei also known as Pichia kudriavzevii is a potentially multidrug-resistant yeast because it is intrinsically resistant to fluconazole and develops acquired resistance to echinocandins and polyenes. Here, we aim...
4.
Arastehfar A, Daneshnia F, Hovhannisyan H, Fuentes D, Cabrera N, Quinteros C, et al.
mBio
. 2023 Sep;
14(5):e0118023.
PMID: 37772846
is a major fungal pathogen, which is able to lose mitochondria and form small and slow-growing colonies, called "petite." This attenuated growth rate has created controversies and questioned the clinical...
5.
Arendrup M, Arikan-Akdagli S, Jorgensen K, Barac A, Steinmann J, Toscano C, et al.
J Infect
. 2023 Aug;
87(5):428-437.
PMID: 37549695
The objectives of this study were to assess Candida spp. distribution and antifungal resistance of candidaemia across Europe. Isolates were collected as part of the third ECMM Candida European multicentre...
6.
Arastehfar A, Daneshnia F, Hovhannisyan H, Fuentes D, Cabrera N, Quintin C, et al.
bioRxiv
. 2023 Jul;
PMID: 37398397
Importance: is a major fungal pathogen, which is able to lose mitochondria and form small and slow-growing colonies, called "petite". This attenuated growth rate has created controversies and questioned the...
7.
Daneshnia F, Hilmioglu-Polat S, Ilkit M, Fuentes D, Lombardi L, Binder U, et al.
J Antimicrob Chemother
. 2023 Apr;
78(6):1488-1494.
PMID: 37100456
Objectives: Although perceived as a rare clinical entity, recent studies have noted the emergence of MDR C. parapsilosis (MDR-Cp) isolates from single patients (resistant to both azole and echinocandins). We...
8.
Arastehfar A, Hilmioglu-Polat S, Daneshnia F, Pan W, Hafez A, Fang W, et al.
Front Cell Infect Microbiol
. 2021 May;
11:676177.
PMID: 33968809
As the second leading etiological agent of candidemia in Turkey and the cause of severe fluconazole-non-susceptible (FNS) clonal outbreaks, emerged as a major health threat at Ege University Hospital (EUH)....
9.
Kaplan E, Aktas D, Dogen A, Hilmioglu-Polat S, Gumral R, Hagen F, et al.
Mycopathologia
. 2021 Jan;
186(1):41-51.
PMID: 33392857
The arthroconidial yeasts Magnusiomyces capitatus and M. clavatus are emerging opportunistic pulmonary pathogens. They are closely related and difficult to distinguish based on morphological and physiological traits. We applied an...
10.
Binder U, Arastehfar A, Schnegg L, Hortnagl C, Hilmioglu-Polat S, Perlin D, et al.
J Fungi (Basel)
. 2020 Dec;
6(4).
PMID: 33353200
While being the third leading cause of candidemia worldwide, numerous studies have shown severe clonal outbreaks due to fluconazole-resistant (FLCR) isolates associated with fluconazole therapeutic failure (FTF) with enhanced mortality....